Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Photomedex Inc (NASDAQ: PHMD)

$1.30 USD -$0.07 (-5.11%)
Last Price $1.3
Net Change $-0.07 (-5.11%)
Bid $0
Ask Price $0
Open Price $1.4
Previous Close Price $1.37
High Price $1.4
Low Price $1.28
Number of Trades 83
Volume 33,100
Fifty Two Week High $5.6 (2016-12-08)
Fifty Two Week Low $0.9 (2016-06-15)
Average Daily Volume 238,546
Share Outstanding 4,420 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $0
Recent Earnings $
Annual EPS $-2.61
Last Quarter EPS $
Market Capitalization $0.01B
Insider Shareholders % 0.2241%
Annual Revenue $0B
No. Shares Outstanding 4,420
Inst. Shareholder % 8.45%
Annual Net Income $0B
TTM Net Profit Margin $100.36
1-Year Return -31.58%
3-Year Return -98.29%
5-Year Return -98.2%
5-Year Revenue Growth -70.93%
5-Year Earnings Growth -100%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD %
Dividends per Share $
Stock Split Ratio 1-5
Beta 0.74
Photomedex, Inc. develops, manufactures and markets therapeutic excimer laser-based instrumentation designed to treat psoriasis and vitiligo. They are also developing their technology for the treatment of other skin disorders. They've received the first Food and Drug Administration, or FDA, approval to market an excimer laser system, XTRAC system, for the treatment of psoriasis. They have commercially launched the XTRAC system in the United States.

PHMD News & Stock Updates